Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Escaned

Showing results (431-440 of 582) with videos related to

Pageof 59
Sort By:
JACC. Cardiovascular Interventions|September 30, 2019
Artificial Intelligence for Aortic Pressure Waveform Analysis During Coronary Angiography: Machine Learning for Patient SafetyJames P Howard, Christopher M Cook, Tim P van de Hoef, et al.
International Journal of Cardiology|January 14, 2023
Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-studyTim P van de Hoef, Valérie E Stegehuis, Maribel I Madera-Cambero, et al.
Journal of the American College of Cardiology|March 19, 2013
Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study)Sayan Sen, Kaleab N Asrress, Sukhjinder Nijjer, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery diseaseSukhjinder S Nijjer, Sayan Sen, Ricardo Petraco, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
Cardiology|February 1, 2014
Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter studyJung-Kyu Han, Bon-Kwon Koo, Kyung-Woo Park, et al.
Journal of the American Heart Association|July 15, 2020
Coronary Flow Capacity to Identify Stenosis Associated With Coronary Flow Improvement After Revascularization: A Combined Analysis From DEFINE FLOW and IDEALTadashi Murai, Valérie E Stegehuis, Tim P van de Hoef, et al.
American Heart Journal|March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trialMitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Pageof 59

Showing results (431-440 of 582) with videos related to

Sort By:
Pageof 59
JACC. Cardiovascular Interventions|September 30, 2019
Artificial Intelligence for Aortic Pressure Waveform Analysis During Coronary Angiography: Machine Learning for Patient SafetyJames P Howard, Christopher M Cook, Tim P van de Hoef, et al.
International Journal of Cardiology|January 14, 2023
Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-studyTim P van de Hoef, Valérie E Stegehuis, Maribel I Madera-Cambero, et al.
Journal of the American College of Cardiology|March 19, 2013
Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study)Sayan Sen, Kaleab N Asrress, Sukhjinder Nijjer, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery diseaseSukhjinder S Nijjer, Sayan Sen, Ricardo Petraco, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
Cardiology|February 1, 2014
Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter studyJung-Kyu Han, Bon-Kwon Koo, Kyung-Woo Park, et al.
Journal of the American Heart Association|July 15, 2020
Coronary Flow Capacity to Identify Stenosis Associated With Coronary Flow Improvement After Revascularization: A Combined Analysis From DEFINE FLOW and IDEALTadashi Murai, Valérie E Stegehuis, Tim P van de Hoef, et al.
American Heart Journal|March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trialMitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Pageof 59